| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
175,679 |
128,861 |
$30.51M |
| G0470 |
Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit |
10,709 |
6,415 |
$2.01M |
| G0466 |
Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
8,588 |
7,229 |
$1.63M |
| T1015 |
Clinic visit/encounter, all-inclusive |
34,403 |
26,491 |
$42K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
86 |
82 |
$39K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
1,657 |
1,266 |
$23K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
88,025 |
67,629 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
33,481 |
26,914 |
$3K |
| 81003 |
|
19,435 |
13,074 |
$339.53 |
| 90656 |
|
643 |
632 |
$225.00 |
| 90716 |
|
2,859 |
2,472 |
$192.07 |
| 90686 |
|
13,072 |
11,140 |
$179.30 |
| 96127 |
|
9,893 |
7,982 |
$159.75 |
| 90707 |
|
2,827 |
2,435 |
$147.07 |
| 90791 |
Psychiatric diagnostic evaluation |
1,789 |
1,503 |
$146.46 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,860 |
1,629 |
$131.93 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
8,756 |
6,979 |
$129.03 |
| 90832 |
Psychotherapy, 30 minutes with patient |
8,021 |
4,920 |
$124.25 |
| 99215 |
Prolong outpt/office vis |
1,092 |
895 |
$123.47 |
| 90633 |
|
3,016 |
2,581 |
$108.00 |
| 90651 |
|
3,073 |
2,654 |
$100.01 |
| 99443 |
|
3,928 |
3,198 |
$86.58 |
| 0001A |
|
1,203 |
1,040 |
$80.00 |
| 92250 |
|
80 |
72 |
$80.00 |
| 90715 |
|
3,377 |
2,857 |
$68.46 |
| 90696 |
|
936 |
838 |
$63.00 |
| 90648 |
|
2,830 |
2,377 |
$56.11 |
| 90670 |
|
5,419 |
4,701 |
$56.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,192 |
3,589 |
$54.41 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
142 |
126 |
$51.31 |
| 99442 |
|
11,252 |
8,731 |
$50.95 |
| 90680 |
|
4,322 |
3,704 |
$40.48 |
| 90723 |
|
1,581 |
1,332 |
$40.00 |
| 0002A |
|
944 |
780 |
$40.00 |
| 99406 |
|
3,179 |
2,709 |
$36.59 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
3,311 |
2,710 |
$31.62 |
| 81025 |
|
6,066 |
5,070 |
$25.83 |
| 0071A |
|
372 |
355 |
$22.72 |
| 3008F |
|
70,558 |
57,435 |
$18.15 |
| 90746 |
|
437 |
398 |
$17.67 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,452 |
2,067 |
$17.66 |
| 90734 |
|
1,590 |
1,410 |
$16.01 |
| 90685 |
|
700 |
592 |
$16.00 |
| Q3014 |
Telehealth originating site facility fee |
693 |
613 |
$14.40 |
| 90834 |
Psychotherapy, 45 minutes with patient |
675 |
460 |
$12.35 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,871 |
6,615 |
$10.03 |
| 90698 |
|
2,802 |
2,352 |
$8.04 |
| 90744 |
|
1,985 |
1,666 |
$8.02 |
| 90700 |
|
979 |
807 |
$8.00 |
| 87210 |
|
2,594 |
2,167 |
$6.87 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
4,138 |
3,300 |
$5.28 |
| 90662 |
|
345 |
281 |
$4.43 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
358 |
252 |
$3.68 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
819 |
727 |
$3.44 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,817 |
1,480 |
$1.82 |
| 93000 |
|
900 |
775 |
$1.15 |
| 87220 |
|
2,467 |
2,067 |
$0.77 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,575 |
4,835 |
$0.12 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
7,113 |
5,998 |
$0.09 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
7,440 |
6,436 |
$0.08 |
| 99441 |
|
3,816 |
3,050 |
$0.02 |
| 99381 |
|
967 |
803 |
$0.02 |
| 92551 |
|
4,138 |
3,519 |
$0.01 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
691 |
590 |
$0.01 |
| 90380 |
|
90 |
79 |
$0.01 |
| 3079F |
|
866 |
669 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,242 |
1,898 |
$0.00 |
| 90677 |
|
1,390 |
1,067 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
703 |
564 |
$0.00 |
| 91307 |
|
733 |
658 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
210 |
170 |
$0.00 |
| 0011A |
|
853 |
782 |
$0.00 |
| 97802 |
|
230 |
147 |
$0.00 |
| 90619 |
|
569 |
441 |
$0.00 |
| 90732 |
|
214 |
195 |
$0.00 |
| 94010 |
|
77 |
73 |
$0.00 |
| 85018 |
|
2,293 |
1,814 |
$0.00 |
| 3074F |
|
1,892 |
1,376 |
$0.00 |
| 3080F |
|
310 |
238 |
$0.00 |
| 99383 |
|
150 |
120 |
$0.00 |
| 99384 |
|
88 |
68 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
53 |
36 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
263 |
227 |
$0.00 |
| 0064A |
|
291 |
288 |
$0.00 |
| 96380 |
|
122 |
109 |
$0.00 |
| 3075F |
|
383 |
313 |
$0.00 |
| 0012A |
|
878 |
777 |
$0.00 |
| 91306 |
|
286 |
283 |
$0.00 |
| 91301 |
|
1,782 |
1,579 |
$0.00 |
| 0072A |
|
285 |
278 |
$0.00 |
| 0500F |
|
185 |
163 |
$0.00 |
| 90480 |
|
235 |
162 |
$0.00 |
| 87428 |
|
356 |
320 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
112 |
110 |
$0.00 |
| 82962 |
|
307 |
251 |
$0.00 |
| 0134A |
|
57 |
56 |
$0.00 |
| 90381 |
|
28 |
28 |
$0.00 |
| 99385 |
|
20 |
14 |
$0.00 |
| 0031A |
|
34 |
28 |
$0.00 |
| 91303 |
|
34 |
28 |
$0.00 |
| 88720 |
|
31 |
24 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
23 |
12 |
$0.00 |
| 0081A |
|
16 |
15 |
$0.00 |
| 90674 |
|
15 |
13 |
$0.00 |
| 0124A |
|
197 |
182 |
$0.00 |
| 0003A |
|
43 |
43 |
$0.00 |
| 97803 |
|
203 |
129 |
$0.00 |
| 3085F |
|
1,207 |
971 |
$0.00 |
| 90863 |
|
58 |
51 |
$0.00 |
| 82274 |
|
834 |
714 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
411 |
375 |
$0.00 |
| 80305 |
|
2,147 |
1,788 |
$0.00 |
| 90713 |
|
13 |
13 |
$0.00 |
| 90473 |
|
1,352 |
1,116 |
$0.00 |
| 99173 |
|
8,943 |
7,776 |
$0.00 |
| 83655 |
|
764 |
570 |
$0.00 |
| 91312 |
|
197 |
182 |
$0.00 |
| 91300 |
|
2,520 |
1,987 |
$0.00 |
| 3078F |
|
1,459 |
1,081 |
$0.00 |
| 3077F |
|
531 |
397 |
$0.00 |
| 0004A |
|
36 |
36 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
67 |
53 |
$0.00 |
| 91320 |
|
153 |
101 |
$0.00 |
| 91311 |
|
40 |
35 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
235 |
161 |
$0.00 |
| 11981 |
|
26 |
26 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
16 |
16 |
$0.00 |
| 91313 |
|
56 |
56 |
$0.00 |
| 91322 |
|
13 |
13 |
$0.00 |